Home > Newsletters > Drug Industry Daily > India to Decide on Price Control Expansions for ‘Essential’ Drugs
Drug Industry Daily
Sept. 27, 2012 | Vol. 11 No. 190
India to Decide on Price Control Expansions for ‘Essential’ Drugs
Indian government health authorities have until today to decide if the government will add price controls to generic medicines beyond the 74 drugs already under price regulation – the latest development in a 17-year dispute over which essential medicines are subject to price controls.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.